Press Releases Prostatype Genomics AB

Equities

PROGEN

SE0014684569

Market Closed - Nasdaq Stockholm Other stock markets 06:43:42 2024-05-08 am EDT			5-day change	1st Jan Change
0.0348 ^SEK	+2.96%		-5.43%	-63.37%

Apr. 18	Prostatype Genomics Announces Very Strong Interim Results from Long-Term Follow-Up Study with Prostatype in Uppsala	CI
Apr. 17	Prostatype Genomics Updates on Significant Progress in the US Study with Prostatype®	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prostatype Genomics publishes Annual Report for 2023	Apr. 25	AQ
NOTICE OF ANNUAL GENERAL MEETING IN PROSTATYPE GENOMICS AB (PUBL)	Apr. 24	AQ
Prostatype Genomics announces outcome of exercise of warrants of series 3 (TO3)	Apr. 19	AQ
Prostatype Genomics announces very strong interim results from long-term follow-up study with Prostatype® in Uppsala	Apr. 18	AQ
Prostatype Genomics updates on significant progress in the US study with Prostatype®	Apr. 17	AQ
Prostatype Genomics announces strong positive final results from multicentre study with Prostatype® in Spain	Apr. 16	AQ
The exercise period for Prostatype Genomic's warrants of series 3 begins today	Apr. 05	AQ
Prostatype Genomics enters into collaboration with Professor E. David Crawford, MD, University of California San Diego, in preparation for the commercial launch of Prostatype® in the United States	Apr. 02	AQ
Prostatype Genomics publishes newsletter on US progress and the long-term follow-up study in Uppsala	Mar. 11	AQ
Prostatype Genomics' long-term study with Uppsala University Hospital will be presented at the AUA conference in the US in May 2024	Feb. 19	AQ
Prostatype Genomics publishes year-end report for 2023	Feb. 15	AQ
Prostatype Genomics receives CAP laboratory accreditation, achieves another milestone towards entering the US market	Feb. 09	AQ
Prostatype Genomics acquires CLIA Certificate to facilitate rapid US market launch with a significantly stronger financial outlook	Feb. 08	AQ
ResearchDx and Prostatype Genomics Inc. in CLIA-laboratory agreement for the US-market	Feb. 05	AQ
Prostatype Genomics AB carries out a directed share issue to guarantors following completed rights issue	Jan. 16	AQ
Prostatype Genomics AB: Rights issue registered and trading in paid subscription units ceases	Jan. 16	AQ
Prostatype Genomics announces final outcome of the Rights Issue	Jan. 10	AQ
Prostatype Genomics announces preliminary outcome of the Rights Issue	Jan. 05	AQ
Long term follow up study at Akademiska University Hospital, Uppsala, to be presented at EAU-meeting, May 2024: Indicates new area of use for Prostatype®	Dec. 22	AQ
Prostatype Genomics publishes monthly newsletter and its net sales for the third quarter of 2023	Dec. 21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Prostatype Genomics AB

Equities

PROGEN

SE0014684569

Press Releases

Filters